BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17483019)

  • 1. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway.
    Zhang G; Chen F; Cao Y; See WA
    Urol Oncol; 2007; 25(3):221-7. PubMed ID: 17483019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guérin through nuclear factor-kappaB and Ap-1 via an immediate early pathway.
    Chen FH; Crist SA; Zhang GJ; Iwamoto Y; See WA
    J Urol; 2002 Aug; 168(2):786-97. PubMed ID: 12131369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.
    Chen F; Langenstroer P; Zhang G; Iwamoto Y; See W
    J Urol; 2003 Nov; 170(5):2009-13. PubMed ID: 14532843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking.
    Chen F; Zhang G; Iwamoto Y; See WA
    BMC Urol; 2005 May; 5():8. PubMed ID: 15890073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.
    Chen F; Zhang G; Cao Y; Hessner MJ; See WA
    J Urol; 2009 Dec; 182(6):2932-7. PubMed ID: 19853870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic polyvalent ligand for α5β1 integrin activates components of the urothelial carcinoma cell response to bacillus Calmette-Guérin.
    Chen F; Zhang G; Cao Y; Wakim B; See WA
    J Urol; 2013 Mar; 189(3):1104-9. PubMed ID: 22999999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
    Chen F; Zhang G; Cao Y; Payne R; See WA
    J Urol; 2007 Nov; 178(5):2166-70. PubMed ID: 17870116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
    Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy.
    Pfister C; Flaman JM; Dunet F; Grise P; Frebourg T
    J Urol; 1999 Jul; 162(1):69-73. PubMed ID: 10379742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical bacillus calmette-guerin (BCG) as inducer of tumor-suppressing proteins p53 and p21 Waf1-Cip1 during treatment of superficial bladder cancer.
    Fontana D; Bellina M; Galietti F; Scoffone C; Cagnazzi E; Guercio S; Cappia S; Pozzi E
    J Urol; 1999 Jul; 162(1):225-30. PubMed ID: 10379791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell].
    Li X; Gong ZY; Li H; Wei Q; Shi M; Yang YR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):177-81. PubMed ID: 15062066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1.
    See WA; Zhang G; Chen F; Cao Y; Langenstroer P; Sandlow J
    BJU Int; 2009 Jun; 103(12):1714-20. PubMed ID: 19154459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder.
    Dekairelle AF; Tombal B; Cosyns JP; Gala JL
    Clin Cancer Res; 2005 Jul; 11(13):4724-32. PubMed ID: 16000567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette-Guérin in transitional cancer cell lines.
    Sandes E; Lodillinsky C; Cwirenbaum R; Argüelles C; Casabé A; Eiján AM
    Int J Mol Med; 2007 Dec; 20(6):823-8. PubMed ID: 17982689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway.
    Takagaki N; Sowa Y; Oki T; Nakanishi R; Yogosawa S; Sakai T
    Int J Oncol; 2005 Jan; 26(1):185-9. PubMed ID: 15586239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes.
    Bilim V; Kawasaki T; Takahashi K; Tomita Y
    J Exp Clin Cancer Res; 2000 Dec; 19(4):483-8. PubMed ID: 11277327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.
    Choi BH; Kim CG; Bae YS; Lim Y; Lee YH; Shin SY
    Cancer Res; 2008 Mar; 68(5):1369-77. PubMed ID: 18316600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.